|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ethoxy-, pentoxy- and benzytoxyphenoxazones and homologues : A series of substrates to distinguish between different induced cytochromes P-450 显示文摘 | Burke MD Thompson S Elcombe CR | 1985 | Biochem Pharmacol1985，34，18： | 1 |
| 2 | Prevalence of dementia in the United States:the aging,demographics,and memory study显示文摘 | Plassman BL Langa KM Fisher GG Heeringa SG Weir DR Ofstedal MB Burke JR Hurd MD Potter GG Rodgers WL Sreffens DC Willis RJ Wallace RB | | 0，，： | 1 |
| 3 | 利用药物遗传学提高药物的安全性和有效性显示文摘药物遗传学是指根据个人的基因型制定药物治疗方案,人们普遍认为它是个体化用药的第一步。在本期杂志中(见223页),Chasman等报道了3-羟基-3-甲基戊二酰辅酶A还原酶(HGMCR)基因中2个常见的多态现象与普伐他汀疗效降低之间的关系。有人调查了与脂质代谢有关的10个基因中的148个单核苷酸的多态性,发现HGMCR基因中含有2个相关单核苷酸多态性的携带者采用药物治疗后, | Susanne B. Haga Wylie Burke, MD 崔艳丽(译) 赵秀丽(校) | 2005 | 美国医学会杂志(中文版)2005，24，4： | 1 |
| 4 | Sunreillance,reporting,automation and interventional epidemiology显示文摘 | John P Burke MD | 2003 | Infect Control Hosp Epidemiol2003，24，1： | 1 |
| 5 | Ethoxy-, pentoxy- and benzy loxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochrome P450 显示文摘 | Burke MD Thomp son S Elcombe CR | 1985 | Biochem Pharmacol1985，34，18： | 1 |
| 6 | Enhanced expression of cytochrome P450 in stomach cancer 显示文摘 | Murray GI Taylor MC Burke MD | 1998 | Br J Cancer1998，77，： | 1 |
| 7 | Cytochrome P450 specifieities of alkoxyresorufin O-dealkylation in human and rat liver显示文摘 | Burke MD Stephanie T Clifford RE | 1994 | Bioehem Pharmaeol1994，48，5： | 1 |
| 8 | Rat cytochrome P450 (CYP) specifically contribute to the reductive bioreductivation of AQ4N,an alkylaminoanthraquinone-di-N-oxide anticancer prodrug显示文摘 | WANOGHO E BURKE MD | 1999 | Xenobiotica1999，29，11： | 1 |
| 9 | Involovement of human cytochrome P450 (CYP)in the reductive metabolism of AQ4N,a hypoxia activated anthraquinone di-n-oxide prodrug显示文摘 | WANOGHO E BURKE MD | 1998 | Bioreductive Therapies1998，42，： | 1 |
| 10 | Enhanced expression of cytochrome P450 in stomach cancer 显示文摘 | Murray GI Taylor MC Burke MD | 1998 | Br J Cancer1998，77，7： | 1 |
| 11 | Ethoxy,pentoxy and benzyloxyphenoxazones and homologues:a series of substrates to distinguish between different induced cytochromes P450显示文摘 | Burke MD Thompson S Elcombe CR | 1985 | Biochemical Pharmacology1985，34，： | 1 |
| 12 | Involovement of human cytochrome P450 (CYP)in the reductive metabolism of AQ4N,a hypoxia activated anthraquinone di-n-oxide prodrug显示文摘 | WANOGHO E BURKE MD | 1998 | Bioreductive Therapies1998，42，： | 1 |
| 13 | for Investigators of the Registry of the Canadian Stroke Network, Short-term outcomes after symptomatic internal carotid artery occlusion 显示文摘 | Burke M J Vergouwen MD Fang J | 2011 | Stroke2011，42，9： | 1 |
| 14 | Short-term outcomes after symptomatic internal carotid artery occlusion显示文摘 | Burke MJ Vergouwen MD Fang J | | 0，，： | 1 |
| 15 | Ethoxy-,pentoxy-and benzy-loxyphenoxazones and homologues:a series of substratesto distinguish between different induced cytochromes P-450显示文摘 | Burke MD Thompson S Elcombe CR Halpert J Haaparanta T Mayer RT | 1985 | Biochem Pharmacol1985，34，18： | 1 |
| 16 | Short-term outcomes after symptomatic internal carotid artery occlusion显示文摘 | BURKE MJ VERGOUWEN MD FANGJ | 2011 | Stroke aJournal of cerebral circulation2011，42，9： | 1 |
| 17 | Ethoxy-, pentoxy-and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450 显示文摘 | Burke MD Thompson S Elcombe CR | 1985 | Biochemical Pharmacology1985，34，18： | 1 |
| 18 | Principles of therapeutic drug monitoring显示文摘 | Burke MD | 1981 | Postgrad M ed1981，70，1： | 1 |
| 19 | Characteristics of a microsomal cytochrome P-488-mediated reaction Ethoxyresorufin O-de-ethylation显示文摘 | Burke MD Prough RA Maryer RT | 1977 | Drug Metab Dispos1977，5，： | 1 |
| 20 | Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug显示文摘 | Raleigh SM Wanogho E Burke MD | 1999 | Xenobiotica1999，29，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员